FIELD: pharmaceutical industry.
SUBSTANCE: composition contains Octreotide and Dalargin in therapeutically effective amounts as active components. Method of composition production includes dissolution of components in purified water followed by lyophilisation of solution.
EFFECT: provides high pancreatropic activity and can be applied for treatment of diseases associated with pancreatic pathology.
5 cl, 3 ex, 5 tbl
Title | Year | Author | Number |
---|---|---|---|
HEXAPEPTIDE POSSESSING ANTIPANCREATONECROTIC ACTIVITY | 0 |
|
SU1348343A1 |
MEANS FOR HYDROPREPARATION OF PANCREAS IN ITS RESECTION | 1997 |
|
RU2139682C1 |
METHOD FOR TREATING ACUTE EXPERIMENTAL PANCREATITIS | 1992 |
|
RU2042359C1 |
METHOD OF RESECTION OF PANCREAS | 1996 |
|
RU2136221C1 |
METHOD OF TREATING PANCREONECROSIS | 2011 |
|
RU2492527C2 |
LIQUEUR | 1992 |
|
RU2031106C1 |
METHOD FOR SIMULATING TOXIC HEPATITIS USING PHTHALIC ANHYDRIDE | 2024 |
|
RU2822194C1 |
METHOD FOR SIMULATING TOXIC HEPATITIS USING 1,2-DIAMINOETHANE | 2024 |
|
RU2821289C1 |
METHOD FOR SIMULATING TOXIC HEPATITIS USING METHYLTRICHLORIDE | 2024 |
|
RU2821264C1 |
METHOD OF TREATING EXPERIMENTAL PANCREATONECROSIS | 2012 |
|
RU2525015C2 |
Authors
Dates
2008-12-20—Published
2007-01-24—Filed